SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-22-058861
Filing Date
2022-05-11
Accepted
2022-05-11 17:05:43
Documents
12
Period of Report
2022-05-11

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2214905d1_6k.htm 6-K 12236
2 EXHIBIT 99.1 tm2214905d1_ex99-1.htm EX-99.1 291348
3 EXHIBIT 99.2 tm2214905d1_ex99-2.htm EX-99.2 199948
4 EXHIBIT 99.3 tm2214905d1_ex99-3.htm EX-99.3 16382
5 EXHIBIT 99.4 tm2214905d1_ex99-4.htm EX-99.4 11136
6 EXHIBIT 99.5 tm2214905d1_ex99-5.htm EX-99.5 11238
7 GRAPHIC tm2214905d1_ex99-2img001.jpg GRAPHIC 19036
8 GRAPHIC tm2214905d1_ex99-2img002.jpg GRAPHIC 23118
9 GRAPHIC tm2214905d1_ex99-2img003.jpg GRAPHIC 19989
10 GRAPHIC tm2214905d1_ex99-2img01.jpg GRAPHIC 18282
11 GRAPHIC tm2214905d1_ex99-2img03.jpg GRAPHIC 37957
12 GRAPHIC tm2214905d1_ex99-2img02.jpg GRAPHIC 32187
  Complete submission text file 0001104659-22-058861.txt   751687
Mailing Address 275 ARMAND-FRAPPIER BLVD. LAVAL A8 H7V 4A7
Business Address 275 ARMAND-FRAPPIER BLVD. LAVAL A8 H7V 4A7 450-680-4500
BELLUS Health Inc. (Filer) CIK: 0001259942 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39034 | Film No.: 22914639
SIC: 2834 Pharmaceutical Preparations